Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
419 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 8 |
| 2012 | 10 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 16 |
| 2016 | 20 |
| 2017 | 29 |
| 2018 | 23 |
| 2019 | 27 |
| 2020 | 30 |
| 2021 | 38 |
| 2022 | 35 |
| 2023 | 19 |
| 2024 | 47 |
| 2025 | 37 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 102 |
| Completed | 93 |
| Unknown status | 64 |
| Terminated | 52 |
| Not yet recruiting | 47 |
| Active, not recruiting | 42 |
| Withdrawn | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 38 |
| M.D. Anderson Cancer Center | 13 |
| National Cancer Institute (NCI) | 12 |
| Sun Yat-sen University | 8 |
| Memorial Sloan Kettering Cancer Center | 7 |
| Chinese Academy of Medical Sciences | 6 |
| Tianjin Medical University Cancer Institute and Hospital | 6 |
| Dana-Farber Cancer Institute | 5 |
| MedSIR | 5 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 419 |
| Breast Neoplasms | 181 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Neoplasm Metastasis | 13 |
| Brain Neoplasms | 10 |
| Breast Neoplasms, Male | 8 |
| Inflammatory Breast Neoplasms | 8 |
| Ovarian Neoplasms | 8 |
| Carcinoma, Renal Cell | 7 |
| Colorectal Neoplasms | 7 |
Trials
Showing 51 to 75 of 419. Each trial links to its page on Pharma Observatory.
319 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.